Items where Subject is "Tuberculosis > Drug Resistant TB"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Item Type
Jump to: | A | B | C | D | G | H | J | K | L | M | N | P | R | S | T | U | V | W | Y
Number of items at this level: 121.

Mahadev, B. and Kumar, P. and Agarwal, S. P. and Chauhan, L. S. and Srikantaramu, N. (2005) Surveillance of drug resistance to anti-tuberculosis drugs in Districts of hoogli in West Bengal and Mayurbhanj in Orissa Indian J Tuberc , 52. pp. 5-10.

Tuberculosis Research Centre, I. C. M. R. (2000) Chemotherapy of drug resistant tuberculosis: the Tuberculosis Research Centre experience over 40 years Chemotherapy of drug resistant tuberculosis the Tuberculosis Research Centre experience over 40 years, 47. pp. 201-210.

A

Aleyamma Thomas, and Rajeswari Ramachandran, and Fathima Rehaman, and Jaggarajamma, K. and Santha, T. and Selvakumar, N. and Nalini Krishnan, and Nalini Sunder Mohan, and Sundaram, V. and Fraser Wares, and Narayanan, P. R. (2007) Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience Indian J Tuberc, 54. pp. 117-124.

Anand, S. and Kumar, P. (2011) The Mumbai incident and India’s response to Drug Resistant Tuberculosis NTI Bulletin, 47. pp. 1-4.

Arora, J. and Sidiq, Z. and Sharma, S. and Singhal, R. and Bhalla, M. and Couvin, D. and Sarin, R. and Rastogi, N. and Myneedu, V. P. (2014) Phylogenetic associations with drug-resistant Mycobacterium tuberculosis isolates in a paediatric population Int J Tuberc Lung Dis, 18 (10). pp. 1172-1179.

B

Bharty, S. and Prakash, B. and Saraf, S. and Rai, R. and Bhatnagar, A. K. and Gupta, U. A. (2014) Initiation of MDR TB treatment: Is hospitalization worth? Indian J Tuberc, 61. pp. 57-64.

Bhat, J. and Rao, V. G. and Yadav, R. and Muniyandi, M. and Sharma, R. and Karfarma, C. and Luke, C. (2015) Situation of drug resistant tuberculosis in Saharia tribe of central India Indian J Med Res, 141 (5). pp. 636-639.

Bhushan, B. and Chander, R. and Kajal, N. C. and Ranga, V. and Gupta, A. and Bharti, H. (2014) Profile of adverse drug reactions in drug resistant tuberculosis from Punjab Indian J Tuberc, 61 (4). pp. 318-324.

Bhutia, R. and Narain, K. and Devi, K. R. and Singh, T. S. and Mahanta, J. (2013) Direct and early detection of Mycobacterium tuberculosis complex and rifampicin resistance from sputum smears Int J Tuberc Lung Dis, 17 (2). pp. 258-261.

C

Chatterjee, A. and Nilgiriwala, K. and Saranath, D. and Rodrigues, C. and Mistry, N. (2017) Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage Tuberculosis (Edinb). 2017 Dec;107:63-72, 107. pp. 63-72.

Chauhan, M. M. and Mahadev, B. and Balasangameshwara, V. H. (1996) Prevention of Acquired Drug Resistance NTI Bulletin, 32 (1&2). p. 14.

Chauhan, M. M. and Satyanarayana, A. V. V. (1995) Causes of Drug Resistance NTI Bulletin, 31 (3&4). p. 54.

Chopra, K. K. and Hanif, M. and Hema Sundaram, (2011) Diagnosis of MDR TB by Rapid Assays NTI Bulletin, 47. pp. 1-8.

Conners, E. and Garfein, R. S. and Rodwell, T. C. and Udwadia, Z. F. and Catanzaro, D. G. (2016) Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India Int J Tuberc Lung Dis, 20 (12). pp. 1633-1638.

Crofton, J. (1987) The Prevention and Management of Drug - Resistant Tuberculosis NTI Newsletter, 23 (1). pp. 49-56.

D

Das, M. and Isaakidis, P. and Van den Bergh, R. and Kumar, A. M. V. and Sharath, B. N. and Mansoor, H. and Saranchuk, P. (2016) Treating all multidrug-resistant tuberculosis patients, not just bacteriologically confirmed cases PHA, 6 (2). p. 157.

Deshmukh, R. D. and Dhande, D. J. and Sachdeva, K. S. and Sreenivas, A. and Kumar, A. M. V. and Satyanarayana , S. and Parmar, M. and Moonan, P. K. and Lo, T. Q. (2015) Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India PLoS ONE, 10 (8). e0135802.

Dhatwalia, S. K. and Yadav, R. and Behera, D. and Rudramurthy, S. M. and Kaur, H. and Sethi, S. (2016) Distribution and association of Mycobacterium tuberculosis CAS lineage with multidrug resistance in North India Int J Tuberc Lung Dis, 20 (6). pp. 806-811.

Dhingra, V. K. and Rajpal, S. and Bhalla, P. and Yadav, A. and Jain, S. K. and Hanif, M. (2003) Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients J. Commun. Dis., 35 (2). pp. 82-89.

Dhingra , V. K. and Malik, S. and Hanif, M. and Arora, V. K. (2009) A report from the New Delhi Tuberculosis Centre, India Journal of the College of Physicians and Surgeons Pakistan, 19 (2). pp. 133-135.

Dhingra , V. K. and Rajpal, S. and Anshu Mittal, and Haniff, M. (2008) Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic Indian J Tuberc, 55. pp. 15-21.

Dusthackeer, A. and Sekar , G. and Chidambaram , S. and Kumar, V. and Mehta, P. and Swaminathan, S. (2015) Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory Indian J Med Res, 2015 (5). pp. 568-574.

G

Georghiou, S. B. and Ajbani, K. and Rodrigues, C. and Rodwell, T. C. (2016) Performance of a pyrosequencing platform in diagnosing drugresistant extra-pulmonary tuberculosis in India Int J Tuberc Lung Dis, 20 (2). pp. 160-165.

Gupta, A. and Singh, S. K. and Anupurba, S. (2015) Mutations at embB306 codon and their association with multidrug resistant M. tuberculosis clinical isolates Indian Journal of Medical Microbiology, 33 (3). pp. 387-392.

Gupta, H. and Kant, S. and Jain, A. and Natu, S. M. and Ahluwalia, S. (2013) Initial drug resistance pattern among pulmonary tuberculosis patients Indian J Tuberc. 2013 Jul;60(3):154-61., 60 (3). pp. 154-161.

Gupta, U. D. and Vemuri, N. and Gupta, P. and Kumar, V. and Tanushree, P. and Khuller, G. K. (2015) Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model Indian J Med Res, 142. pp. 323-329.

H

Hanif, M. and Malik, S. and Dhingra, V. K. (2009) Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India Int J Tuberc Lung Dis, 13 (1). pp. 74-78.

J

Jain, A. and Singh, P. K. and Chooramani, G. and Dixit, P. and Malhotra, H. S. (2016) Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India Int J Tuberc Lung Dis, 20 (7). pp. 870-875.

Jain, A. K. and Puri, M. M. and Sarin, R. (2017) Black brown discoloration and hairy tongue – A rare linezolid side effect Indian J Tuberc, 64. pp. 44-46.

Joseph, M. R. and Shoby, C. T. and Amma, G. R. and Chauhan, L. S. and Paramasivan, C. N. (2007) Surveillance of anti-tuberculosis drug resistance in Ernakulam Distrct, Kerala State, South India Int J Tuberc Lung Dis, 11. pp. 443-449.

Joseph, P. and Chandrasekaran, V. and Thomas, A. and Gopi, P. G. and Rajeswari, R. and Balasubramanian, R. and Subramani, R. and Selvakumar, N. and Santha, T. (2006) Influence of drug susceptibility on treatment outcome and susceptibility profile of 'failures' to category II regimen Indian J Tuber, 53. pp. 141-148.

Joseph, P. and Desai, V. B. R. and Mohan, N. S. and Fredrick, J. S. and Ramachandran, R. and Raman, B. and Wares, F. and Ramachandran, R. and Thomas, A. (2011) Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India Indian J Med Res, 133 (5). pp. 529-534.

K

Kambli, P. and Nikam, C. and Shetty, A. and Soman, R. and Rodrigues, C. (2016) Multi‑drug resistant tuberculous meningitis Indian J Med Microbiol, 34 (2). p. 255.

Kashmira Limaye, and Swapna Kanade, and Gita Nataraj, and Preeti Mehta, (2010) Utility of microscopic observation of drug susceptibility (mods) assay for Mycobacterium Tuberculosis in resource constrained settings Indian J Tuberc, 57. pp. 207-212.

Kumar, P. and Kumar, P. and Balooni, V. and Singh, S. (2015) Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India Int J Tuberc Lung Dis, 19 (4). pp. 434-439.

Kumar, R. and Garg, R. and Kant, S. and Verma, S. K. and Kushwaha, R. A. S. and Kumar, S. and Jain, A. (2016) High correlation of clinical criteria in the diagnosis of drug-resistant TB and prevalence of ofloxacin resistance Int J Tuberc Lung Dis, 20 (10). pp. 1354-1357.

Kumar, R. S. and Kumar, A. M. and Claassens, M. and Banurekha, V. V. and Sekar , G. and Venkatesan, P. and Swaminathan, S. (2014) Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results? Int J Tuberc Lung Dis, 18 (4). pp. 449-453.

L

Lakshmi, R. and Ramachandran, R. and Kumar, D. R. and Sundar, A. S. and Radhika , G. and Rahman, F. and Selvakumar, N. and Kumar, V. (2015) Revisiting the susceptibility testing of Mycobacterium tuberculosis to ethionamide in solid culture medium Indian J Med Res, 142 (5). pp. 538-542.

M

Mahadev, B. and Jagota, P. and Srikantaramu, N. and Gnaneshwaran, M. (2003) Surveillance of Drug Resistance in Mysore District, Karnataka NTI Bulletin, 39 (3&4). pp. 5-10.

Mahadev, B. and Kumar, P. and Agarwal, S. P. and Chauhan, L. S. and Srikantaramu, N. (2005) Survillance of drug resistance to anti-tuberculosis drugs in districts of Hoogli in West Bengal and Mayurbhanj in Orissa Int J Tuberc, 52. pp. 5-10.

Majumdar, T. and Bhattacharya, S. and Barman, D. and Bhoumik, P. and Bir, R. (2016) Detection of multidrug-resistant tuberculosis using MGITTM and MAS-PCR in Tripura, India Int J Tuberc Lung Dis, 20 (2). pp. 166-169.

Malhotra, B. and Goyal, S. and Bhargava, S. and Reddy, P. V. and Chauhan, A. and Tiwari, J. (2015) Rapid detection of rifampicin resistance in Mycobacterium tuberculosis by high-resolution melting curve analysis Int J Tuberc Lung Dis, 19 (12). pp. 1536-1541.

Manu, M. K. and Mohapatra, A. K. and Magazine, R. (2013) Extrpulmonary multidrug resistant tuberculosis presenting as chest wall abscess –a rare case report Indian J Tuberc. pp. 121-123.

Mehra, M. and Kambili, C. and Potluri, R. and Rhines, A. and Singh, V. and Thomas, A. (2017) Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India Int J Tuberc Lung Dis, 21 (8). pp. 902-909.

Myneedu, V. P. and Visalakshi, P. and Verma, A. K. and Behera, D. and Bhalla, M. (2011) Prevalence of XDR TB cases – a retrospective study from a tertiary care TB hospital Indian J Tuberc, 58. pp. 54-59.

N

Naganathan, N. (1984) Panel Discussion on Treatment & Drug Resistance in Tuberculosis NTI Newsletter, 20 (2 ). pp. 34-38.

Nair, D. and Velayutham, B. and Kannan, T. and Tripathy, J. P. and Harries, A. D. and Natrajan, M. and Swaminathan, S. (2017) Predictors of unfavourable treatment outcome in patients with multidrug-resistant tuberculosis in India PHA, 7 (1). pp. 32-38.

Natt , N. K. and Nagpal, M. and Chawla, N. and Singh, T. and Deepika, and Singh, H. (2014) Prevalence, patterns, characteristics and challenges in management of multi-drug resistant tuberulosis cases under DOTS-PLUS Indian J Tuberc, 61 (3). pp. 207-2012.

Neeta Singla, and Rupak Singla, and Sheron, Fernandes S. and Digamber Behera, (2009) Post treatment sequelae of multi-drug resistant tuberculosis patients Indian J Tuberc, 56 (4). pp. 206-212.

Nikam, C. and Patel, R. and Sadani, M. and Ajbani, K. and Kazi, M. and Soman, R. and Shetty, A. and Georghiou, S. B. and Rodwell, T. C. and Catanzaro, A. and Rodrigues, C. (2016) Redefining MTBDRplus test results: what do indeterminate results actually mean? Int J Tuberc Lung Dis, 20 (2). pp. 154-159.

Noman Siddiqi, and Mohammed Shamim, and Seema Hussain, and Rakesh Kumar Choudhary, and Niyaz Ahmed, and Prachee, and Sharmistha Banerjee, and Savithri, G. R. and Mahfooz Alam, and Niteen Pathak, and Amol Amin, and Mohammed Hanief, and Katoch, V. M. and Sharma, S. K. and Sayed Hasnain, E. (2002) Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India Antimicorbial Agents and Chemotherapy, 46 (2). pp. 443-450.

P

Padmapriyadarsini, C. and Yogendra, V. B. and Joseph, B. and Murali, L. (2017) Multidrug resistant tuberculosis during pregnancy Indian J Tuberc, 64. pp. 63-64.

Panda, B. N. and Jena, J. and Rai, S. P. and Chatterji, R. S. (2000) Supervised chemotherapy in pulmonary tuberculosis and emergence of drug resistance in cases of relapse Indian J Tuberc, 47. pp. 163-166.

Panwalkar, N. and Chauhan, D. S. and Desikan, P. (2017) Spoligotype Defined Lineages of Mycobacterium tuberculosis and Drug Resistance: Merely a Casual Correlation? Indian J Med Microbiol, 35 (1). pp. 27-32.

Paramasivan, C. N. (2003) Status of Drug Resistance in Tuberculosis after the Introduction of Rifampicin in India J Indian Med Assn, 101 (3). pp. 154-156.

Paramasivan, C. N. and Bhaskaran, K. and Venkataraman, P. and Chandrasekaran, V. and Narayanan, P. R. (2000) Surveillance of drug resistance in tuberculosis in the state of Tamilnadu Indian J Tuber, 47. pp. 27-33.

Paramasivan, C. N. and Rehman, F. and Wares, F. and Sundar Mohan, N. and Sundar, S. and Devi, S. and Narayanan, P. R. (2010) First- and second-line drug resistance patterns among previously treated tuberculosis patients in India Int J Tuberc Lung Dis, 14 (2). pp. 243-246.

Paramasivan, C. N. and Venkataraman , P, (2004) Drug resistance in tuberculosis in India Indian J Med Res, 120. pp. 377-386.

Prignot, J. (1993) Multidrug Resistance of Tubercle Bacilli - Fact and Implication for National Programme NTI Newsletter, 29 (3&4). pp. 45-47.

R

Rai, S. P. (2013) Tackling Extensively Drug Resistant Tuberculosis (XDR-TB) Indian J Tuberc, 60 (2). pp. 67-70.

Rai, S. P. and Panda, B. N. (2004) Outcome in multidrug resistant tuberculosis patients with ambulatory treatment Indian J Tuberc , 51. pp. 33-36.

Raizada, N. and Sachdeva, K. S. and Nair, S. A. and Kulsange, S. and Gupta, R. S. and Thakur, R. and Parmar, M. and Gray, C. and Ramachandran, R. and Vadera, B. and Ekka, S. and Dhawan, S. and Babre, A. and Ghedia, M. and Alavadi, U. and Dewan, P. and Khetrapal, M. and Khanna, A. and Boehme, C. and Paramsivan, C. N. (2014) Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB PLoS ONE, 9 (8). e105346.

Ramachandran, R. and Lakshmi, R. and Ravi Kumar, D. and Devika, K. and Rahman, F. and Wares, D. F. (2011) Fast track method for the identification of multi-drug resistant tuberculosis on direct clinical specimen using combined drug media Asian Pacific Journal of Tropical Disease. pp. 47-49.

Ramachandran, R. and Nalini, S. and Chandrasekar, V. and Dave, P. V. and Sanghvi, A. S. and Wares, F. and Paramasivan, C. N. and Narayanan, P. R. and Sahu, S. and Parmar, M. and Chadha, S. (2009) Surveillance of drug-resistant tuberculosis in the state of Gujarat, India Int J Tuberc Lung Dis, 13 (09). pp. 1154-1160.

Ramakrishnan, C. V. and Bhatia, A. L. and Devadatta, S. and Fox, W. and Narayana, A. S. L. and Selkon, J. B. and Velu, S. (1962) The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance to isoniazid Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS Bull World Health Organ, 26. pp. 1-18.

Ramesh, V. and Manas, K. Sen and Deepthi Nair, and Rupak Singla, and Amitava Sengupta, (2011) Cutaneous tuberculosis caused by multidrug-resistant tubercle bacilli: Report of three cases International Journal of Dermatology, 50. pp. 300-303.

Ramesh, V. and Manas, K. Sen and Sethuraman, G. and D’Souza, P. (2015) Cutaneous tuberculosis due to multidrug-resistant tubercle bacilli and difficulties in clinical diagnosis Indian Journal of Dermatology, Venereology, and Leprology, 81 (4). pp. 380-384.

Raveendran, R. and Oberoi, J. K. and Wattal, C. (2015) Multidrug-resistant pulmonary & extrapulmonary tuberculosis: A 13 years retrospective hospital-based analysis Indian J Med Res, 142 (5). pp. 575-582.

Ravindra Kumar Dewan, and Himanshu Pratap, (2006) Surgical interventions in multidrug-resistant tuberculosis: Retrospective analysis of 74 patients treated at a tertiary level care centre Ind J Thorac Cardiovas Surg, 22. pp. 15-18.

S

Salvo, F. and Dorjee, K. and Dierberg, K. and Cronin, W. and Sadutshang, T. D. and Migliori, G. B. and Rodrigues, C. and Trentini, F. and Di Serio, C. and Chaisson, R. and Cirillo , D. M. (2014) Survey of tuberculosis drug resistance among Tibetan refugees in India Int J Tuberc Lung Dis, 18 (6). pp. 655-622.

Santha, T. and Radhakrishna, S. and Ramakrishnan, C. V. and Tripathy, S. P. (1976) Retreatment of drug-sensitive relapses of pulmonary tuberculosis following chemotherapy with standard drugs Tubercle, 57. pp. 177-180.

Santha, T. and Thomas, A. and Chandrasekaran, V. and Selvakumar, N. and Gopi, P. G. and Subramani, R. and Rajeswari, R. and Rani, B. and Paramasivan, C. N. and Perumal, M. and Wares, F. and Narayanan, P. R. (2006) Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in south India Int J Tuberc Lung Dis, 10 (1). pp. 52-57.

Sarah Mathew, and Nalini, S. M. and Fathima Rahman, and Aszhgar Dastageer, and Sundaram, V. and Paramasivan, C. N. (2007) Simple direct drug susceptibility tests on sputum samples for early detection of resistance in tubercle bacilli Indian J Tuberc, 54. pp. 184-189.

Sarin, R. and Singla, R. and Visalakshi, P. and Jaiswal, A. and Puri, M.M. and Khalid, U. K. and Mathuria, K. and Singla, N. and Behera, D. and Sharma, P. P. (2010) Smear microscopy as surrogate for culture during follow up of pulmonary MDR-TB patients on dots plus treatment Indian J Tuberc, 57. pp. 134-140.

Selvakumar, N. (2000) Multi-Drug Resistant Tuberculosis . pp. 133-145.

Selvaraj, P. and Chandra, G. and Kurian, S. M. and Reetha, A. M. and Narayanan, P. R. (2003) Association of vitamin D receptor gene variants of Bsm I, Apa I and Fok I polymorphisms with susceptibility or resistance to pulmonary Tuberculosis Curr Sci, 84 (12). pp. 1564-1568.

Sharma, S. K. and Chaubey, J. and Singh, B. K. and Sharma, R. and Mittal, A. and Sharma, A. (2017) Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India Int J Tuberc Lung Dis, 21 (10). pp. 1112-1117.

Shewade, H. D. and Govindarajan, S. and Sharath, B. N. and Tripathy, J. P. and Chinnakali, P. and Kumar, A. M. V. and Muthaiah, M. and Vivekananda, K. and Paulraj, A. K. and Roy, G. (2015) MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn’t and why? PHA, 5 (2). pp. 132-139.

Shewade, H. D. and Govindarajan, S. and Thekkur, P. and Palanivel, C. and Muthaiah, M. and Kumar, A. M. V. and Gupta, V. and Sharath, B. N. and Tripathy, J. P. and Vivekananda, K. and Roy, G. (2016) MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway PHA, 6 (4). pp. 242-246.

Shringarpure, K. S. and Isaakidis, P. and Sagili, K. D. and Baxi, R. K. (2015) Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It PLoS ONE, 10 (7). e0132543.

Shrivastava, N. and Set, R. and Bankar, S. and Shastri, J. (2017) Detection of Ofloxacin Resistance by Nitrate Reductase Assay in Mycobacterium tuberculosis Isolates from Extrapulmonary Tuberculosis Indian J Med Microbiol, 35 (1). pp. 69-73.

Singh, A. and Gopinath, K. and Sharma, P. and Bisht, D. and Sharma, P. and Singh, N. and Singh, S. (2015) Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant Indian J Med Res, 141 (1). pp. 27-45.

Singh, N. and Sidiq, Z. and Bhalla, M. and Myneedu, V. P. and Sarin, R. (2014) Multi-drug resistant tuberculosis among category I treatment failures - a retrospective study Indian J Tuberc, 61. pp. 148-151.

Singh, S. (2014) Early detection of multi-drug resistant tuberculosis in India using GenoType MTBDRplus assay & profile of resistance mutations in Mycobacterium tuberculosis Indian J Med Res, 140. pp. 477-479.

Singh, S. and Tripathy, S. K. and Kumar, P. (2016) An overview of Programmatic Management of Drug Resistance Tuberculosis (PMDT) in India NTI Bulletin, 52 (1-4). pp. 2-11.

Singhal, P. and Dixit, P. and Singh, P. and Jaiswal, I. and Singh, M. and Jain, A. (2016) A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India Indian J Med Res, 143 (3). pp. 341-347.

Singhal, R. and Myneedu, V. P. and Arora, J. and Singh, N. and Bhalla, M. and Verma, A. and Sarin, R. (2015) Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay Indian Journal of Medical Microbiology, 33 (Supp 1). S46-S52.

Singhal, R. and Myneedu, V. P. and Arora, J. and Singh, N. and Sah, G. C. and Sarin, R. (2014) Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North-eastern states of India using GenoType MTBDRplus assay Indian J Med Res, 140. pp. 501-506.

Singla, N. and Singla, R. and Jain, G. and Habib, L. and Behera, D. (2011) Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India Int J Tuberc Lung Dis, 15 (10). pp. 1326-1330.

Singla, N. and Singla, R. and Jain, G. and Habib, L. and Behera, D. (2011) Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India Int J Tuberc Lung Dis, 15 (10). pp. 1326-1330.

Singla, R. and Arora, V. K. (2014) Multi-drug resistant tuberculosis in India Indian J Tuberc, 61. pp. 9-11.

Singla, R. and Gupta, S. and Gupta, R. and Arora, V. K. (2001) Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary TB patients: preliminary results Int J Tuberc Lung Dis, 5 (6). pp. 559-563.

Somashekar, M. and Anil, S. and Naik, B. and Volkmann, T. and Sagili, K. D. and Akshatha, J. S. and Buggi, S. and Sharada, M. A. and Chadha, V. K. and Moonan, P. K. (2016) Drug-Induced Hypothyroidism during Anti-Tuberculosis Treatment of Multidrug-Resistant Tuberculosis: Notes from the Field J Tuberc Res, 4 (3). pp. 105-110.

Subbaiah, T. V. and Mitchison, D. A. and Selkon, J. B. (1960) The susceptibility to hydrogen peroxide of Indian and British isoniazid-sensitive and isoniazid-resistant tubercle bacilli Tubercle, 41 (5). pp. 323-333.

Surendra, K. Sharma and Ninoo George, and Tamilarasu Kadhiravan, and Pradip, K. Saha and Hemant, K. Mishra and Mahmud Hanif, (2009) Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital based study Indian J Med Res, 130. pp. 392-395.

Suryawanshi, S. L. and Shewade, H. D. and Nagaraja, S. B. and Nair, S. A. and Parmar, M. (2017) Unfavourable outcomes among patients with MDR-TB on the standard 24-month regimen in Maharashtra, India PHA, 7 (2). pp. 116-122.

Swaminathan, S. and Padmapriyadarsini, C. and Narendran, G. and Thomas, B. E. and Anand, S. and Rajyalakshmi, A. (2005) Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis Indian J Chest Dis Allied Sci, 47. pp. 299-304.

T

Thakur, C. and Kumar, V. and Gupta, A. K. (2015) Detecting mutation pattern of drug‑resistant Mycobacterium tuberculosis isolates in Himachal Pradesh using GenoType® MTBDRplus assay Indian Journal of Medical Microbiology, 33 (4). pp. 547-553.

Thakur, C. and Verma, S. and Negi, R. S. and Kumar, V. (2017) Lophomonas blattarum co-infection in a patient with multidrug-resistant tuberculosis Int J Tuberc Lung Dis, 21 (10). pp. 1185-1187.

Thomas, A. and Joseph, P. and Nair, D. and Rao, D. V. and Rekha, V. V. and Selvakumar, N. and Jaggarajamma, K. and Balambal, R. (2011) Extensively drug-resistant tuberculosis: experience at the Tuberculosis Research Centre, Chennai, India Int J Tuberc Lung Dis, 15 (10). pp. 1323-1425.

Thomas, A. and Ramachandran, R. and Rehaman, F. and Jaggarajamma, K. and Santha, T. and Selvakumar , N. and Krishnan, N. and Mohan, N. S. and Sundaram, V. and Wares, F. and Narayanan, P. R. (2007) Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience Indian J Tuberc, 54. pp. 117-124.

Ti, T. and Lwin, T. and Mar, T. T. and Maung, W. and Noe, P. and Htun, A. and Kluge, H. H. and Wright, A. and Aziz, M. A. and Paramasivan, C. N. (2006) National anti-tuberculosis drug resistance survey,2002, in Myanmar Int J Tuberc Lung Dis, 10 (10). pp. 1111-1116.

Tripathi, R. and Sinha, P. and Kumari, R. and Chaubey, P. and Pandey, A. and Anupurba, S. (2016) Detection of rifampicin resistance in tuberculosis by molecular methods: A report from Eastern Uttar Pradesh, India Indian Journal of Medical Microbiology, 34 (1). pp. 92-94.

Tripathi, U. C. and Nagaraja, S. B. and Tripathy, J. P. and Sahu, S. K. and Parmar, M. and Rade, K. and Bhatnagar, S. and Ranjan, A. and Sachdeva, K. S. (2015) Follow-up examinations: are multidrug-resistant tuberculosis patients in Uttar Pradesh, India, on track? PHA, 5 (1). pp. 59-64.

Tuberculosis Chemotherapy Centre, (1968) Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India Part I Findings in urban clinics among patients giving no history of previous chemotherapy Indian J Med Res, 56. pp. 1617-1630.

Tuberculosis Research Centre, (2001) Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy Int J Tuberc Lung Dis, 5 (1). pp. 40-45.

Tuberculosis Research Centre, (2011) Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases Int J Tuberc Lung Dis, 15 (6). pp. 782-788.

Tuberculosis Research Centre, (2003) Trends in initial drug resistance over three decades in a rural community in South India Ind J Tub, 50. p. 75.

U

Udwadia, Z. F. and Amale, R. A. and Mullerpattan, J. B. (2014) Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India Int J Tuberc Lung Dis, 18 (11). pp. 1315-1318.

V

Vadwai, V. and Ajbani, K. and Jose, M. and Vineeth, V. P. and Nikam, C. and Deshmukh, M. and Shetty, A. and Soman, R. and Rodrigues, C. (2013) Can inhA mutation predict ethionamide resistance? Int J Tuberc Lung Dis, 17 (1). pp. 129-130.

Varma, M. and Kumar, S. and Kumar, A. and Bose, M. (2002) Comparison of Etest and agar proportion method of testing drug susceptibility of M. tuberculosis Ind.J Tub, 490. p. 217.

Varma-Basil, M. and Prasad, R. (2015) Dilemmas with ethionamide susceptibility testing of Mycobacterium tuberculosis: A microbiologist & physician’s nightmare Indian J Med Res, 142 (5). pp. 512-514.

Velayutham, B. and Nair, D. and Kannan, T. and Padmapriyadarsini, C. and Sachdeva, K. S. and Bency, J. and Klinton, J. S. and Haldar, S. and Khanna, A. and Jayasankar, S. and Swaminathan, S. (2016) Factors associated with sputum culture conversion in multidrugresistant pulmonary tuberculosis Int J Tuberc Lung Dis, 20 (12). pp. 1671-1676.

Velayutham, B. and Nair, D. and Ramalingam, S. and Perez-Velez, C. M. and Becerra, M. C. and Swaminathan, S. (2015) Setting priorities for a research agenda to combat drug-resistant tuberculosis in children PHA, 5 (4). pp. 222-235.

Vellarikkal, S. K. and Patowary, A. and Singh, M. and Periwal, V. and Singh, A. V. and Singh, P. K. and Garg, P. and Katoch, V. M. and Katoch, K. and Jangir, P. K. and Sharma, R. and Open Source Drug Discovery Consortium, and Chauhan, D. S. and Scaria, V. and Sivasubbu, S. (2013) Draft Genome Sequence of a Clinical Isolate of Multidrug-Resistant Mycobacterium tuberculosis East African Indian Strain OSDD271 Genome Announcements, 1 (4). e00541-13.

Vellarikkal, S. K. and Singh, A. V. and Singh, P. K. and Garg, P. and Katoch, V. M. and Katoch, K. and Open Source Drug Discovery Consortium, and Chauhan, D. S. and Scaria, V. and Sivasubbu, S. (2013) Draft Genome Sequence of an Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolate of the Ural Strain OSDD493 Genome Announcements, 1 (6). e00928-13 .

Vellarikkal, S. K. and Singh, A. V. and Singh, P. K. and Garg, P. and Katoch, V. M. and Katoch, K. and Open Source Drug Discovery Consortium, and Chauhan, D. S. and Sivasubbu, S. and Scaria, V. (2013) Draft Genome Sequence of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolate OSDD515, Belonging to the Uganda I Genotype Genome Announcements, 1 (6). e00750-13.

Vellarikkal, S. K. and Singh, A. V. and Singh, P. K. and Garg, P. and Katoch, V. M. and Katoch, K. and Open Source Drug Discovery Consortium, and Chauhan, D. S. and Sivasubbu, S. and Scaria, V. (2013) Draft Genome Sequence of a Multidrug-Resistant Clinical Isolate of Mycobacterium tuberculosis Belonging to a Novel Spoligotype Genome Announcements, 1 (6). e00965-13 .

Venkataraman, P. and Paramasivan, C. N. (2003) Drug resistance in Tuberculosis and issues related to multidrug resistance in planning for TB control India Health Administrator, XV (1&2). pp. 127-136.

W

Wares, F. and Falzon, D. (2014) Progress in achieving universal access to care for multidrug- resistant tuberculosis (MDR-TB) Indian J Tuberc, 61 (4). pp. 298-306.

Y

Yadav, R. and Sethi, S. and Dhatwalia, S. K. and Gupta, D. and Mewara, A. and Sharma, M. (2013) Molecular characterisation of drug resistance in Mycobacterium tuberculosis isolates from North India Int J Tuberc Lung Dis, 17 (2). pp. 251-257.

This list was generated on Thu Nov 23 13:25:44 2017 IST.